Germany’s Bayer has offered $62 billion for US agricultural group Monsanto in a move that would create the world’s biggest supplier of seeds and fertilizers. The takeover bid is subject to regulatory approval.
German drugs and chemicals group Bayer said Monday it had offered $62 billion (55 billion euros) for US agrochemicals giant Monsanto. Should the transaction be finalized, the merger would create the world’s biggest producer of pesticides, seeds and fertilizers.
Bayer said in a statement it had made a cash offer of $122 per share, following weeks of speculation about a possible tie-up.
Monsanto had first disclosed Bayer’s approach last Wednesday, but neither side had provided details on any proposed terms of the deal.
Bayer said it was in advanced discussions with banks about financing the deal, and said any money it would have to borrow to finalize the deal could be quickly repaid due to “the strong cash-flow generation of the combined business, as well as Bayer’s track record of disciplined deleveraging after large acquisitions.”
Full Content: DW
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
OpenAI Board Denies Receiving Formal Bid from Elon Musk
Feb 12, 2025 by
CPI
Thomas Kauper, Former DOJ Antitrust Leader, Dies at 89
Feb 12, 2025 by
CPI
BlackRock’s Acquisition of Preqin Secures UK Regulatory Approval
Feb 12, 2025 by
CPI
NFL Sued Over Bluesky Ban by Fans Citing Antitrust Violations
Feb 12, 2025 by
CPI
Warburg Pincus Strikes $1 Billion Deal to Acquire Vermont Information Processing
Feb 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – International Criminal Enforcement
Jan 23, 2025 by
CPI
The Antitrust Division’s Recent Work to Combat International Cartels
Jan 23, 2025 by
Emma Burnham & Benjamin Christenson
Information Sharing: The New Frontier of U.S. Antitrust Enforcement
Jan 23, 2025 by
Brian P. Quinn, Casey Kovarik & Michael Tubach
The Key Role of Guidelines on Exchanges of Information Among Competitors and the Divergent Transatlantic Paths
Jan 23, 2025 by
Rosa Abrantes-Metz & Albert Metz
Leniency, Whistleblowers, and Compliance
Jan 23, 2025 by
Richard Powers, Tara O’Malley & Cory Gordon